Algeta Receives IND Approval for Alpharadin(TM) to Commence Clinical Development in the USA
uccessthe impact of competition the ability to close viable and profitablebusiness deals the risk of non-approval of patents not yet granted anddifficulties of obtaining relevant governmental approvals for new products.
Date:2/21/2008